The Canadian digital asset firm DeFi Technologies is navigating a period of significant pressure. A wave of class-action lawsuits filed by multiple U.S. law firms alleges securities fraud and misleading statements by company leadership. This legal onslaught arrives as the company’s shares have plummeted more than 77% from their peak in May, following a disappointing third-quarter earnings report. Investors are now weighing whether the current negative sentiment is justified or excessive.
Despite the turmoil, the company continues to execute its growth strategy. A key subsidiary, Valour, listed four new products on Brazil’s B3 exchange on December 4th. Furthermore, DeFi Technologies reported a record $987 million in assets under management (AUM) and has already surpassed its milestone of launching 100 crypto-focused Exchange Traded Products (ETPs) in Europe.
Portfolio companies are also making headway. Stablecorp, in which DeFi Technologies holds an interest, received regulatory approval for QCAD, the first compliant Canadian dollar-based stablecoin. Concurrently, subsidiary Stillman Digital launched a dark pool tailored for institutional investors.
The legal complaints focus on alleged misconduct between May and November 2025. Prominent firms, including Bronstein, Gewirtz & Grossman, contend that the company failed to disclose material problems with its core “DeFi Alpha” arbitrage strategy — a primary revenue driver. Additional accusations include downplaying competitive threats and maintaining unrealistic revenue projections for the 2025 fiscal year.
Should investors sell immediately? Or is it worth buying DeFi Technologies?
These lawsuits were precipitated by the November 14 quarterly results, which fell sharply short of market expectations. The company posted revenue of $22.5 million and operating income of $9 million, representing a nearly 20% decline in sales. This performance forced a drastic reduction in the full-year outlook. Co-founder Olivier Roussy Newton simultaneously stepped down as CEO, handing the role to Johan Wattenström.
Market analysts have responded decisively to the altered landscape. Benchmark slashed its price target radically from $8 to $3, though it maintained a “Buy” rating. Northland Capital Markets halved its target from $5 to $2.50.
The equity’s performance reflects this profound uncertainty. Year-to-date, the shares are down over 55%. The contrast is particularly stark since its Nasdaq listing in May, with the stock losing approximately 77% of its value since that high. Currently trading in a technically oversold condition, the share price exhibits extreme volatility, underscored by a beta of 4.05.
The immediate future for investors is likely to be dominated by legal proceedings. A critical date is January 30, 2026, by which time lead plaintiffs must step forward for the class-action process, a move that will significantly shape the trajectory of the litigation.
